CStone Pharmaceuticals
HKEX:2616

Watchlist Manager
CStone Pharmaceuticals Logo
CStone Pharmaceuticals
HKEX:2616
Watchlist
Price: 1.81 HKD
Market Cap: 2.3B HKD
Have any thoughts about
CStone Pharmaceuticals?
Write Note

CStone Pharmaceuticals
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CStone Pharmaceuticals
Net Change in Cash Peer Comparison

Comparables:
6160
603392
002252
300122
300896

Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
CStone Pharmaceuticals
HKEX:2616
Net Change in Cash
ÂĄ438m
CAGR 3-Years
-15%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Net Change in Cash
-ÂĄ5.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Net Change in Cash
-ÂĄ1.4B
CAGR 3-Years
N/A
CAGR 5-Years
-52%
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Net Change in Cash
-ÂĄ1.7B
CAGR 3-Years
-180%
CAGR 5-Years
-53%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Net Change in Cash
ÂĄ2.2B
CAGR 3-Years
-21%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Imeik Technology Development Co Ltd
SZSE:300896
Net Change in Cash
-ÂĄ705.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is CStone Pharmaceuticals's Net Change in Cash?
Net Change in Cash
438m CNY

Based on the financial report for Jun 30, 2024, CStone Pharmaceuticals's Net Change in Cash amounts to 438m CNY.

What is CStone Pharmaceuticals's Net Change in Cash growth rate?
Net Change in Cash CAGR 5Y
-15%

Over the last year, the Net Change in Cash growth was 151%. The average annual Net Change in Cash growth rates for CStone Pharmaceuticals have been -15% over the past three years , -15% over the past five years .

Back to Top